Correlation Engine 2.0
Clear Search sequence regions


  • androgen receptor (1)
  • apoptosis (1)
  • cellular (1)
  • female (1)
  • GLUT4 (2)
  • glycolipid (1)
  • granulosa cells (1)
  • Grim19 (15)
  • HAS2 (1)
  • human granulosa cells (2)
  • humans (1)
  • insulin (1)
  • mice (3)
  • NADPH (2)
  • NDUFA13 (1)
  • new diagnosis (1)
  • ovary (10)
  • pathogenesis (2)
  • patients (3)
  • protein human (1)
  • PTX3 (1)
  • RAC1 (2)
  • serum (1)
  • women (1)
  • Sizes of these terms reflect their relevance to your search.

    Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women. Retinoid-interferon-induced mortality 19 (GRIM19) is a functional component of mitochondrial complex I that plays a role in cellular energy metabolism. However, the role of GRIM19 in the pathogenesis of PCOS is still unclear. To investigate the role of GRIM19 in the pathogenesis of PCOS. We first measured the expression of GRIM19 in human granulosa cells (hGCs) from patients with and without PCOS (n = 16 per group), and then established a PCOS mouse model with WT and Grim19+/- mice for in vivo experiments. Glucose uptake-related genes RAC1 and GLUT4 and energy metabolism levels in KGN cells were examined in vitro by knocking down GRIM19 in the cell lines. Additionally, ovulation-related genes such as p-ERK1/2, HAS2, and PTX3 were also studied to determine their expression levels. GRIM19 expression was reduced in hGCs of PCOS patients, which was negatively correlated with BMI and serum testosterone level. Grim19+/- mice with PCOS exhibited a markedly anovulatory phenotype and disturbed glycolipid metabolism. In vitro experiments, GRIM19 deficiency inhibited the RAC1/GLUT4 pathway, reducing insulin-stimulated glucose uptake in KGN cells. Moreover, GRIM19 deficiency induced mitochondrial dysfunction, defective glucose metabolism, and apoptosis. In addition, GRIM19 deficiency suppressed the expression of ovulation-related genes in KGN cells, which was regulated by dihydrotestosterone mediated androgen receptor. GRIM19 deficiency may mediate ovulation and glucose metabolism disorders in PCOS patients. Our results suggest that GRIM19 may be a new target for diagnosis and treatment. Copyright © 2024 Elsevier B.V. All rights reserved.

    Citation

    Lin Yang, Yang Yang, Xiaojuan Han, Chengzi Huang, Ying Wang, Danni Jiang, Lan Chao. GRIM19 deficiency aggravates metabolic disorder and ovarian dysfunction in PCOS. Biochimica et biophysica acta. Molecular basis of disease. 2024 Apr;1870(4):167063

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38360073

    View Full Text